Europe PMC
open access
Progesterone in feminizing gender affirming hormone therapy: study protocol for a randomized placebo-controlled trial
Background Transgender women receiving feminizing hormone therapy increasingly request progesterone based on anecdotal reports of improved breast development, sleep, mood, and quality of life. However, evidence supporting progesterone as an adjunct to feminizing gender-affirming hormone ther
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea#901864
- Transgender and non-binary people’s experience of living with endometriosis#1169158
- Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy#1173105
- FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients#807056
- Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS#803007
Record · ID 1038710
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive